Are you more of a sweet vanilla or bright and tropical scent?

Indonesian prosecutors are seeking up to 10 years in prison for alleged members of a cross-border baby trafficking ring ...

Indonesian prosecutors are seeking up to 10 years in prison for alleged members of a cross-border baby trafficking ring ...

A Singapore couple told CNA that they were handed a baby in a restaurant in Malaysia and told to take her and go, without any ...

A case that began after authorities rescued six newborns bound for the city-state has put the spotlight on a widespread ...

When it comes to Nintendo's Rhythm Paradise Groove, there are a ton of mini-games to master and overcome. The mode in question will determine which mini-games you will be facing, as things do somewhat ...

Eli Lilly's Jacob Van Naarden says Lilly is using the financial strength from its GLP-1 drugs like Mounjaro and Zepbound to fund its new dealmaking strategy. Van Naarden recently became Lilly's head ...

AlzeCure Pharma CEO Martin Jonsson and CSO Johan Sandin. (AlzeCure Pharma) Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease ...

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare initiative, representatives for the companies told Fierce. The cutbacks ...

Positive data on Eli Lilly's obesity and diabetes candidate retatrutide highlighted the Amercian Diabetes Association Scientific Sessions last weekend in New Orleans. () It’s a sign of the times that ...

Eli Lilly is deepening the case for its asset to help a wide range of patients in need of chronic weight management. (Fraiser Kansteiner) Even as Zepbound and Mounjaro fire on all cylinders and ...

It would put it ahead of Eli Lilly (LLY 2.34%), the pharmaceutical giant that has become the leader in obesity drugs. That's not to knock Eli Lilly, which happens to be a behemoth in its own right, ...